Mutations involving GATA2 coding sequence are not common in sporadic AML cases, and are frequently associated with a more specific subgroup of AML with normal cytogenetics and biallelic CEBPA mutations. The gene discussed is CEBPA; the disease is acute myeloid leukemia.